2022. The Effect of Long-Acting Beta-2 Agonist Monotherapy and Long-Acting Anticholinergic Monotherapy to Quality-of-Life in Group B Stable COPD Patients. Jurnal Respirologi Indonesia. 42, 4 (Sep. 2022), 277–281. DOI:https://doi.org/10.36497/jri.v42i4.370.